Print PDF
What the Potential Elimination of the Biologics Price Competition and Innovation Act Means for Pharmacy
December 1, 2020
Pharmacy Times

On December 1, Axinn partner Chad Landmon participated in a video interview with the Pharmacy Times. Chad gave a brief overview on the arguments being presented to the Supreme Court regarding the legislative change to the ACA and the implications of a decision by the Supreme Court on the ACA. He also outlined what the BPCIA is and how a ruling by the Supreme Court could affect the act.

Click here to access the interview.

By using the Axinn, Veltrop & Harkrider LLP website with cookies enabled on your browser, you agree to our use of cookies during your browsing experience. Learn more about our privacy policy.